P53 in cytoplasm may enhance the accuracy of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase

Oncogene

Volumn 23, Issue 41, 2004, Pages 6890-6899

  Bakhanashvili, Mary ^a,b   Novitsky, Elena ^a   Lilling, Gila ^a   Rahav, Gilia ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

3 5 exonuclease; Cytoplasmic p53; DNA replication fidelity; HIV 1 RT

Indexed keywords

DNA; PHOSPHODIESTERASE I; PROTEIN P53; RNA DIRECTED DNA POLYMERASE; EXODEOXYRIBONUCLEASE;

ARTICLE; CELL FRACTIONATION; CELL STRAIN MCF 7; CYTOPLASM; DNA REPLICATION; DNA SYNTHESIS; DNA TEMPLATE; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS GENOME; WESTERN BLOTTING; BIOSYNTHESIS; DNA REPAIR; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; TUMOR CELL LINE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MINK CELL FOCUS-FORMING VIRUS; RNA VIRUSES;

CELL LINE, TUMOR; CYTOPLASM; DNA; DNA REPAIR; DNA REPLICATION; EXODEOXYRIBONUCLEASES; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MUTATION; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

EID: 4644241504     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207846     Document Type: Article

References (44)

1. Albrechtsen N, Dornreiter I, Grosse F, Kim E, Wiesmuller L and Deppert W. (1999). Oncogene, 18, 7708-7717.
2. Bakhanashvili M. (2001a). Eur. J. Biochem., 268, 2047-2254.
3. Bakhanashvili M. (2001b). Oncogene, 20, 7635-7644.
4. Bakhanashvili M and Hizi A. (1992a). FEBS Lett., 306, 151-156.
5. Bakhanashvili M and Hizi A. (1992b). Biochemistry, 31, 9393-9398.
6. Bakhanashvili M and Hizi A. (1993). Biochemistry, 32, 7559-7567.
7. Bakhanashvili M and Hizi A. (1996). Arch. Biochem. Biophys., 334, 89-96.
8. Bouhamdan M, Benichou S, Rey F, Navarro J, Agostini I, Spire B, Camonis J, Slupphaug G, Vigne R, Benarous R and Sire J. (1996). J Virol., 70, 697-704.
9. Clark PK, Ferris AL, Miller DA, Hizi A, Kim KW, Deringer-Boyer SM, Mellini ML, Clark AD, Arnold GF, Lebherg WB, Arnold EIII, Muschik GM and Hughes SH. (1990). AIDS Res. Hum. Retroviruses, 6, 753-764.
10. Coffin JM. (1986). Cell, 46, 1-4.
11. Echols H and Goodman MF. (1991). Ann. Rev. Biochem., 60, 477-511.
12. Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, Richman DD, Carson DA, Corbeil J and Leoni LM. (2001). FASEB J., 15, 5-6.
13. Goodman MF and Fygenson DK. (1998). Genetics, 148, 1475-1482.
14. Grand RJA, Grant MI and Gallimore PH. (1994). Virology, 203, 229-240.
15. Hizi A, McGill C and Hughes SH. (1988). Proc. Natl. Acad. Sci. USA, 85, 1218-1222.
16. Howley PM. (1991). Cancer Res., 51, 5019s-5022s.
17. Huang P. (1998). Oncogene, 17, 261-270.
18. Hwang BJ, Ford JM, Hanawalt PC and Chu G. (1999). Proc. Natl. Acad. Sci. USA, 96, 424-428.
19. Katz R and Skalska AM. (1990). Ann. Rev. Genet., 24, 409-445.
20. Kunkel T. (1988). Cell, 53, 837-840.
21. Lane DP. (1992). Nature, 358, 15-16.
22. Lilling G, Novitsky E, Sidi Y and Bakhanashvili M. (2003). Oncogene, 22, 233-245.
23. Mansky LM. (1996). Virology, 222, 391-400.
24. Mansky LM. (1997). Trends Genet., 13, 134-136.
25. Mansky LM and Temin HM. (1995). J. Virol., 69, 5087-5094.
26. Mell C and Nasheuer H. (2002). Nucl. Acids Res., 30, 1493-1499.
27. Mendelman LV, Petruska JS and Goodman MF. (1990). J. Biol. Chem., 265, 2338-2346.
28. Menendez-Arias L, (2002). Prog. Nucl. Acid Res. Mol. Biol., 71, 91-147.
29. Mummenbrauer T, Janus F, Muller B, Wiesmuller L, Deppert W and Grosse F. (1996). Cell, 85, 1089-1099.
30. Nermut MV and Fassati A. (2003). J Virol., 77, 8196-8206.
31. Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC and Rotter V. (2001). Oncogene, 20, 581-589.
32. Oren M, Maltzman W and Levine AJ. (1981). Mol. Cell. Biol., 1, 101-110.
33. Perrino FW, Preston BD, Sandell LL and Loeb LA. (1989). Proc. Natl. Acad. Sci. USA, 86, 8343-8347.
34. Prives C and Hall PA. (1999). J. Pathol., 187, 112-126.
35. Shaheen F, Duan L, Zhu M, Bagasra O and Pomeranz RJ. (1996). J. Virol., 70, 3392-3400.
36. Shakked Z, Yavnilovitch M, Kalb AJ, Kessler N, Wolkowicz R, Rotter V and Haran TE. (2002). Oncogene, 21, 5117-5126.
37. Shevelev IV and Hubscher U. (2002). Nat. Rev., 3, 1-12.
38. Skalski V, Lin Z, Choi BY and Brown KR. (2000). Oncogene, 19, 3321-3329.
39. Sluis-Cremer N, Arion D and Parniak MA. (2000). Cell. Mol. Life Sci., 57, 1408-1422.
40. Soussi T. (2000). Ann. NY Acad. Sci., 910, 121-137.
41. Svarovskaia ES, Cheslock SR, Zhang W, Hu W and Pathak VK. (2003). Front. Biosci., 8, d117-d134.
42. Szekely L, Pokrovskaya K, Jiang WQ, Selivanova G, Lowbeer M, Ringertz N, Wiman KG and Klein G. (1995). Oncogene, 10, 1869-1874.
43. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA and Jay G. (1995). Nat. Genet., 9, 41-47.
44. Zhang H, Dornadula G and Pomerantz R. (1996). J. Virol., 70, 2809-2824.